Evidence map›Paper›PMID 41643899›Full record

ArticleMucosal immunology2026

Mycobacterium tuberculosis preferentially infects specific macrophage subsets in primate granulomas during the early stages of tuberculosis.

Davide Pisu, Persis S Sunny, Molly L Nelson, Beth F Junecko, Roopa Venugopalan, Mark A Rodgers, H Jacob Borish, Pauline Maiello, Charles A Scanga, Philana Ling Lin and 3 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Davide PisuDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Persis S SunnyDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Molly L NelsonDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Beth F JuneckoDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Roopa VenugopalanDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mark A RodgersDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
H Jacob BorishDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pauline MaielloDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Charles A ScangaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Philana Ling LinCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Pediatrics, Children's Hospital of the University of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
JoAnne L FlynnDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
David G RussellDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. Electronic address: dgr8@cornell.edu.
Joshua T MattilaDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: jmattila@pitt.edu.

Funding

Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
A mechanistic understanding of tuberculosis progression through bacterial reporter strainsR01AI134183 · NIAID · CORNELL UNIVERSITY · PI RUSSELL, DAVID G · 2017 to 2021
$3.5M
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TBR01AI164970 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bryan David Bryson, Joshua T. Mattila · 2022 to 2026
$2.7M
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infectionR21AI167710 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MATTILA, JOSHUA T. · 2022 to 2023
$420k
BSL3 Flow Sorter for Human Pathogens of Global SignificanceS10OD032135 · OD · CORNELL UNIVERSITY · PI RUSSELL, DAVID G · 2022 to 2022
$362k
NIAID NIH HHS R01 AI134183NIAID NIH HHS R01 AI164970NIAID NIH HHS R21 AI167710NIAID NIH HHS UC7 AI180311NIH HHS S10 OD032135
6 · The paper itself

Abstract

Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) infection and defined by formation of granulomas, immune aggregates that can restrict or support bacterial replication. Macrophages are fundamental components of granulomas and TB pathogenesis, yet their population structure and functional diversity is incompletely understood. The interaction between macrophages and Mtb in vivo, including which cell subsets are infected and how they respond to colonization, is a major determinant of disease outcome. Here, we profiled lung tissue and granulomas from Mtb-infected cynomolgus macaques, an animal model that closely recapitulates human TB, to define macrophage biology in the early stage of infection. We identified distinct subsets, including embryonic-origin tissue resident alveolar macrophages (AMs), monocyte-derived AMs, and interstitial macrophages with distinct spatial localization in granulomas. Tissue-resident AMs and a novel macrophage subset undergoing epithelial-to-mesenchymal transition were the most frequently infected cells in lung tissue. Mtb-infected cells specifically expressed immune-related and migration-associated genes, suggesting that Mtb induces or exploits these pathways in early infection as a survival strategy in vivo. Our findings highlight the complex interplay between macrophage heterogeneity and functional states that serve as a driver of susceptibility to Mtb infection and TB progression.

Indexed as

GranulomaLungMacrophagesMycobacterium tuberculosisTuberculosis, PulmonaryAnimalsDisease Models, AnimalHost-Pathogen InteractionsHost TropismHumansMacaca fascicularisMacrophages, AlveolarGranulomaMacrophageMycobacterium tuberculosisNonhuman primateSingle cell RNA-seqTuberculosis

Identifiers

PMID41643899
PMCPMC13335628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.